INDIAN PHARMA INDUSTRY: CHANGING DYNAMICS_An essay by R. Bowya

INTRODUCTION:                  

 The Indian pharmaceutical market is in the midst of exciting times. While growth accelerated considerably, industry structure has changed through a spate of high profile acquisitions. Traditional commercial models are fast losing the ability to differentiate. New opportunities are gaining critical mass. Discontinuities in the broader healthcare landscape are further intensifying these dynamics. Hence further steps taken by government for the growth of pharma industry. Now days the special training also recommended for the pharma students for the knowledge of pharma industry. Let’s see the details about pharma industry and their changing dynamics.

PHARMA INDUSTRY:

The pharma industry is place main role in pharmaceutical departments. This contains various departments like executive office, production department, and quality control department, research work undertaking departments, exporting and importing departments. Indian pharma done many advanced work in drug action, improving the stability of drug, minimizing the side effects. The Indian pharmaceutical market has characteristics that make it unique. Three levels of characteristics available

1. Branded generics dominate, making up for 70 to 80 % of retail market

2. Local players have enjoyed a dominant position driven by formulation development capabilities and early investments

3. Price level are low, driven by intense competition

These characteristics present their own opportunities and challenges. Examples of developing Indian pharma industries are ,

1. GlaxoSmithKline

2. NovartisIndia limited

3. WyethIndia limited

4. Aventis pharma India

Changing dynamics in pharma industry:

The pharmaceutical industry is undergoing a rapid change, influenced by multiple factors. The context in which the industry operates is dictated by the constantly evolving social , demographic and economic factors, which have major implications in the way the pharmaceutical industry markets and sells its products .

1.     Growth of  bulk  drug exports  in India:

                         Indian bulk drug exports are likely to grow at a compounded annual growth rate of 12 to 14 percent till 2018 to 2019.same period the bulk drug exports share raised to 50 percent by Indian manufactures by the process of better chemistry skills, low manufacture costs, cost reduction initiatives by large global companies. Still the Indian pharma exports many goods to another countries with minimum cost and more active .

2. Changing in drug action:  

Changing in drug action meant that manufacturing of sustained released drugs for the diabetes and cardiovascular disease. It avoids the adverse effect cause by the drug when taken repeated dose. This type of tablet half amount show immediate action and remaining will producing the sustained released. Now day’sIndian pharma manufacturing this type dosage forms for improving the drug action, reducing side effects and improving patient compliance.

3. Changing in affordability and accessibility:

                             The pharma industries focus on the affordability and accessibility of healthcare of peoples. They tries to controls the patient compliance and market dominance. Apart from effectiveness and safety of drug therapy also take care by the pharma industry.

4. Import of technical machine:

                                  The advanced machines are import byIndia for the development of manufacturing and evaluation studies.  India import many machines by many countries like japan, US. Making use of that we improving our manufacturing units, maintain the drug purity, and less workers are need.

5. Hospital channel influence in retail market:

Pharma industry retail market basedon the hospitals. Now days the hospital act as a channel for industries. They get goods from industries and prescribed to the patient and check the bioavailability and side effects and inform to the industry   up to date about the drug, if any adverse effect in that drug they  inform  to the  companies and they withdraw the drug . 80 to 90 percent of market share taken by the hospitals.

6. Growth of vaccine market:

The pharma industries are focus on the vaccine development, because many diseases in India control by the drugs but not cure completely. So the pharmaceutical biotechnologies focus on these departments. Government also made several plans for making development of pharma industry.

CONCLUSION:

       “WHEN YOUR FAIL; THAT IS STEP FOR YOUR SUCCESS”

Likewise we are Indians try to developing our country. There may be we get fail but one day we show our power. The   Indian pharma is developing well now days one day it may become world first industries, that depends on the Indian pharmacy students. If they dream that in future the dreams become true.